Reverse circadian dosing may improve control in patients, but it is evident from a pharmacokinetic study in patients with 21OHD-CAH that, despite taking prednisone and dexamethasone late at night, ACTH and 17OHP still show an exaggerated rise in the morning (38). This evidence concerns the gene POMC and congenital adrenal hyperplasia.